Democratizing Data-Driven Medicine, together. AI-driven and cloud-powered, we help clinicians to generate real-time, actionable insights for patients with cancer and rare disorders. Since day one, we have believed that the field of data-driven medicine requires a technology platform capable of analyzing complex health data (“multimodal data”) and breaking data silos within and across institutions. Our AI-driven platform, SOPHiA DDM™, decentralizes mountains of health data and connects seemingly obscure points within that data to inspire breakthroughs for the toughest medical mysteries. In other words, SOPHiA DDM™ was designed to decentralize data-driven medicine – uncovering answers and enabling healthcare providers across the globe to make data-driven decisions for each patient within the walls of their own institution. SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA. They believed technology could make a positive and lasting impact on the world, using data for good. Their vision was to build a future in which each patient has equal access to world-class care, and today, we are well underway…
Democratizing Data-Driven Medicine, together. AI-driven and cloud-powered, we help clinicians to generate real-time, actionable insights for patients with cancer and rare disorders. Since day one, we have believed that the field of data-driven medicine requires a technology platform capable of analyzing complex health data (“multimodal data”) and breaking data silos within and across institutions. Our AI-driven platform, SOPHiA DDM™, decentralizes mountains of health data and connects seemingly obscure points within that data to inspire breakthroughs for the toughest medical mysteries. In other words, SOPHiA DDM™ was designed to decentralize data-driven medicine – uncovering answers and enabling healthcare providers across the globe to make data-driven decisions for each patient within the walls of their own institution.
SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA. They believed technology could make a positive and lasting impact on the world, using data for good. Their vision was to build a future in which each patient has equal access to world-class care, and today, we are well underway to realizing that impact. We’ve built a revolutionary technology platform that distills complex data into actionable insights to reshape the way that cancer and rare inherited disorders are diagnosed and treated. We’re pioneering the field of data-driven medicine, where our platform’s AI-driven insights, at the heart of one of the strongest connected networks in the world, benefit patients both today and tomorrow.
SOPHiA GENETICS est une société de biotechnologie suisse américaine dont le siège est à Lausanne et Boston. Il fournit des analyses génomiques et radiomiques pour les hôpitaux. L'entreprise a été classée parmi les 50 entreprises les plus intelligentes par le MIT Technology Review en 2017.
Le numéro de téléphone est réservé aux adhérents French Tech Pays Basque. Se connecter ou adhérer au réseau pour y accéder.
Un e-mail de contact réservé aux adhérents French Tech Pays Basque est disponible sur cette fiche. Adhérer au réseau pour y accéder.
